Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/10/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 12k | $90.43 | $1.1M | | 08/10/2023 |
03/16/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 36k | $93.41 | $3.4M | | 03/15/2023 |
03/15/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Stock Option (Right to buy Common Stock) | 38.4k | $87.74 | $3.4M | | 03/15/2023 |
03/15/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 16.8k | $0.00 | $0 | | 03/15/2023 |
03/15/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 4.8k | $87.74 | $421.1k | | 03/15/2023 |
02/28/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 36.4k | $0.00 | $0 | | 02/28/2023 |
02/28/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 18.2k | $0.00 | $0 | | 02/28/2023 |
02/28/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 13.4k | $0.00 | $0 | | 02/28/2023 |
01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 01/20/2023 |
01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 7.5k | $45.66 | $343.4k | | 01/20/2023 |
03/16/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 2.3k | $80.72 | $182.3k | | 03/15/2022 |
03/15/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Stock Option (Right to buy Common Stock) | 35.8k | $78.27 | $2.8M | | 03/15/2022 |
03/15/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 38.8k | $0.00 | $0 | | 03/15/2022 |
03/15/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 12.1k | $78.27 | $947.1k | | 03/15/2022 |
03/08/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 12.8k | $0.00 | $0 | | 03/08/2022 |
02/11/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2.1k | $104.76 | $219k | | 02/11/2022 |
02/11/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 8.7k | $105.80 | $920.4k | | 02/11/2022 |
02/11/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 210 | $106.34 | $22.3k | | 02/11/2022 |
02/11/2022 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 6k | $20.54 | $123.2k | | 02/11/2022 |
02/11/2022 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 5k | $20.54 | $102.7k | | 02/11/2022 |
01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 01/14/2022 |
01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 3.7k | $124.31 | $458.5k | | 01/14/2022 |
03/22/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 2.5k | $78.52 | $192.7k | | 03/22/2021 |
03/16/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 2.3k | $77.21 | $174.4k | | 03/15/2021 |
03/15/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Stock Option (Right to buy Common Stock) | 37.7k | $78.39 | $3M | | 03/15/2021 |
03/15/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 15.3k | $0.00 | $0 | | 03/15/2021 |
03/15/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 7.5k | $78.39 | $584.8k | | 03/15/2021 |
01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 1.5k | $0.00 | $0 | | 01/15/2021 |
01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 2.2k | $214.47 | $462.2k | | 01/15/2021 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 10k | $20.54 | $205.4k | | 12/15/2020 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.2k | $230.19 | $280.4k | | 12/15/2020 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.4k | $232.01 | $324.6k | | 12/15/2020 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 4.5k | $233.40 | $1M | | 12/15/2020 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 610 | $234.27 | $142.9k | | 12/15/2020 |
12/15/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.8k | $235.19 | $428.3k | | 12/15/2020 |
|